BMJ 2017; 357 doi: https://doi.org/10.1136/bmj.j1415
Cite this as: BMJ 2017;357:j1415
Akbar K Waljee, assistant professor1 2 3 4, Mary A M Rogers, research associate professor2 4 5, Paul Lin, statistican2,Amit G Singal, associate professor6, Joshua D Stein, associate professor2 7 8, Rory M Marks, associate professor 9,John Z Ayanian, professor2 5 8, Brahmajee K Nallamothu, professor 1 2 4 10
Correspondence to: A K Waljee firstname.lastname@example.org
Objective To determine the frequency of prescriptions for short term use of oral corticosteroids, and adverse events (sepsis, venous thromboembolism, fractures) associated with their use.
Design Retrospective cohort study and self controlled case series.
Setting Nationwide dataset of private insurance claims.
Participants Adults aged 18 to 64 years who were continuously enrolled from 2012 to 2014.
Main outcome measures Rates of short term use of oral corticosteroids defined as less than 30 days duration. Incidence rates of adverse events in corticosteroid users and non-users. Incidence rate ratios for adverse events within 30 day and 31-90 day risk periods after drug initiation.
Results Of 1 548 945 adults, 327 452 (21.1%) received at least one outpatient prescription for short term use of oral corticosteroids over the three year period. Use was more frequent among older patients, women, and white adults, with significant regional variation (all P - 0.001). The most common indications for use were upper respiratory tract infections, spinal conditions, and allergies. Prescriptions were provided by a diverse range of specialties. Within 30 days of drug initiation, there was an increase in rates of sepsis (incidence rate ratio 5.30, 95% confidence interval 3.80 to 7.41), venous thromboembolism (3.33, 2.78 to 3.99), and fracture (1.87, 1.69 to 2.07), which diminished over the subsequent 31-90 days. The increased risk persisted at prednisone equivalent doses of less than 20 mg/day (incidence rate ratio 4.02 for sepsis, 3.61 for venous thromboembolism, and 1.83 for fracture; all P - 0.001).
Conclusion One in five American adults in a commercially insured plan were given prescriptions for short term use of oral corticosteroids during a three year period, with an associated increased risk of adverse events.